RespireRx Pharmaceuticals Inc. Intellectual Property Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sublicense Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd. dated August 3, 2023
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
IL
2023
Exclusive License Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd. (August 3, 2023)
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
DE
2023
Second Amendment to Exclusive License Agreement between University of Illinois and RespireRx Pharmaceuticals Inc.
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
2023
Patent License Agreement between University of Wisconsin-Milwaukee Research Foundation, Inc. and RespireRx Pharmaceuticals Inc.
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
WI
2020
Exclusive License Agreement between University of Illinois and Cortex Pharmaceuticals, Inc.
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
IL
2020
Patent License Agreement between University of Alberta and Cortex Pharmaceuticals, Inc. for AMPAKINE® Compounds
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
CA
2020
Exclusive License Agreement between University of Illinois and Cortex Pharmaceuticals, Inc.
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
IL
2014
Fifth Amendment to License Agreement Between Cortex Pharmaceuticals, Inc. and The Regents of the University of California
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
2011
Amendment to License Agreement (Control No. 1993-04-0412) between Cortex Pharmaceuticals and The Regents of the University of California
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
2010
License Agreement between Cortex Pharmaceuticals, Inc. and Biovail Laboratories International SRL (March 25, 2010)
License Agreements
RespireRx Pharmaceuticals Inc.
Pharmaceuticals
NY
2010